Medicines Development places Development Manager at Hatchtech

June 10, 2013

Medicines Development and Hatchtech are pleased to announce that Michael Wheatcroft has joined Hatchtech as Senior Development Manager under the Development Manager training and placement initiative supported by the Victorian Government’s Smart SME’s Innovation and Commercialisation Program.

While remaining an employee of Medicines Development, Michael will be a part of the Hatchtech team to progress the development of their proprietary next generation head lice treatment which has successfully completed a Phase IIb clincial trial and is posed to enter Phase III.